What is the interpretation of a patient's kidney function with a Blood Urea Nitrogen (BUN) of 6, Glomerular Filtration Rate (GFR) of 88, and creatinine of 0.86?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kidney Function Interpretation: Mildly Reduced GFR in Context of Low BUN

These laboratory values indicate mildly reduced kidney function for a young adult, with the notably low BUN of 6 mg/dL suggesting either decreased protein intake, overhydration, or reduced muscle mass rather than kidney disease. 1

GFR Assessment

The GFR of 88 mL/min/1.73 m² represents approximately 30% below the expected normal range for young adults (120-130 mL/min/1.73 m²), which is clinically significant and warrants further evaluation. 1

  • A GFR of 88 mL/min/1.73 m² falls below the threshold (90 mL/min/1.73 m²) used for kidney donor acceptance, indicating this is not considered optimal kidney function for younger individuals 1
  • This level does not meet criteria for CKD stage 3 (GFR <60 mL/min/1.73 m²) but may represent CKD stage 2 if markers of kidney damage are present 2
  • The creatinine of 0.86 mg/dL appears normal but can mask reduced GFR, particularly in individuals with lower muscle mass 2, 3

BUN Interpretation

The BUN of 6 mg/dL is abnormally low and suggests factors unrelated to kidney dysfunction:

  • Low BUN typically indicates decreased protein intake, liver disease, overhydration, or reduced muscle mass rather than kidney pathology 4
  • The BUN/creatinine ratio of approximately 7:1 (normal 10:1 to 20:1) is markedly low, supporting non-renal causes for the low BUN 5
  • Higher BUN levels are associated with adverse renal outcomes in CKD patients, but low BUN does not confer kidney protection 4

Required Follow-Up Actions

Do not rely on a single GFR calculation - confirmation with repeat testing and additional markers is essential: 1

  1. Repeat GFR assessment in 3 months to determine if this represents persistent kidney dysfunction versus laboratory variability 1

  2. Measure urine albumin-to-creatinine ratio (ACR) in a random urine specimen, as persistent proteinuria is the principal marker of kidney damage and defines CKD stage 2 when GFR is 60-89 mL/min/1.73 m² 1, 2

  3. Assess for causes of low BUN: evaluate dietary protein intake, hydration status, liver function, and muscle mass 4, 5

  4. Do not use serum creatinine alone to assess kidney function, as it is insensitive to mild-to-moderate GFR decreases and affected by muscle mass, age, and other non-renal factors 2, 6

Clinical Decision Points

If repeat GFR remains <90 mL/min/1.73 m² AND proteinuria is present:

  • This confirms CKD stage 2 and requires nephrology referral for comprehensive evaluation 1
  • Initiate blood pressure control targeting <130/80 mmHg with ACE inhibitor or ARB if proteinuria present 2
  • Evaluate and control cardiovascular risk factors including dyslipidemia 2

If repeat GFR normalizes or proteinuria is absent:

  • The initial low GFR may represent measurement variability, dehydration, or medication effects 2
  • Continue annual monitoring if risk factors for CKD are present (diabetes, hypertension, family history) 2

Important Caveats

  • GFR estimates >60 mL/min/1.73 m² have reduced accuracy, and values just below 90 mL/min/1.73 m² require clinical context for interpretation 2, 7
  • The MDRD equation used for GFR estimation has not been fully validated in healthy individuals or those with near-normal kidney function 2, 3
  • Medication dosing adjustments are generally not required until GFR falls below 60 mL/min/1.73 m² unless using nephrotoxic agents 2

Related Questions

What is the best management approach for an adult patient with chronic kidney disease (CKD), impaired renal function (GFR 38), elevated blood urea nitrogen (BUN) and creatinine levels, hypernatremia (sodium 146), and potential history of hypertension or diabetes?
What does low blood urea nitrogen (BUN) and urea level indicate in a patient?
What are the management strategies for a patient with a Glomerular Filtration Rate (GFR) below 15?
What are the implications and management of a patient with low Blood Urea Nitrogen (BUN) and elevated creatinine indicating Impaired Renal Function?
Is an estimated Glomerular Filtration Rate (eGFR) of 77 and estimated Creatinine Clearance (eCrCl) values ranging from 62 to 77 indicative of normal kidney function?
Can serrapeptase increase the risk of thrombosis, particularly in patients with a history of cardiovascular disease or those at risk for thrombosis?
Is ivermectin cream a suitable treatment for skin cancer, specifically basal cell carcinoma or squamous cell carcinoma?
What is the recommended antibiotic treatment for a patient with otitis media who is allergic to Penicillin (PCN)?
What is the diagnosis and treatment for a patient with suspected vestibular syndrome, presenting with symptoms of dizziness, vertigo, and nausea?
What is the likely diagnosis for a patient with a lifelong history of hyperlipidemia (elevated lipids) and hypertriglyceridemia (elevated triglycerides), a family history of the same, and borderline high Hemoglobin A1c (HbA1c), and what management approach is recommended?
What causes a decrease in carbon dioxide (CO2) levels in a patient with end-stage renal disease (ESRD) undergoing dialysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.